Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN GI research
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Year in review: UMSL sees transformative change during 2024
Look back at some of UMSL Daily’s top stories from the past year.
MORE IN GI research
LATEST NEWS
- Year in review: UMSL sees transformative change during 2024
- Social work student marshal Zeth Crews grows professionally at Places for People
- Veteran Ryan Manley graduates with information systems and technology degree
- Sociology graduate Addi Nunnelly applying lessons from the classroom in her work in the community
- New Doctor of Business Administration cohort features students with diverse professional backgrounds
- Biology graduate Julia Talbert working as research assistant at the Danforth Plant Science Center
- McDonnell Foundation supporting St. Louis Public Radio initiative to improve dialogue across differences
- UMSL receives $5.1 million grant to promote evidence-based literacy strategies in Missouri schools and area career centers
- New graduates celebrate their triumphs with family members, friends during fall 2024 commencement
- Language student Theresa Kallal finds meaning living life abroad in France and Spain
